review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Ruihua Wei | Q89745684 |
Vicki L Ea | Q93018805 | ||
P2093 | author name string | Na Li | |
Lu Zhao | |||
Hong Nian | |||
Yankai Wei | |||
P2860 | cites work | Exosome-orchestrated hypoxic tumor microenvironment | Q64100292 |
Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics | Q64103462 | ||
Role of Exosomes in the Regulation of T-cell Mediated Immune Responses and in Autoimmune Disease | Q64243791 | ||
Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization | Q64275072 | ||
The Challenges and Promise of Complement Therapeutics for Ocular Diseases. | Q64905140 | ||
Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. | Q64957921 | ||
Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins | Q81726606 | ||
Activated T cells recruit exosomes secreted by dendritic cells via LFA-1 | Q82876007 | ||
Sjögren's syndrome | Q85953559 | ||
MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells | Q88597093 | ||
Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway | Q88984389 | ||
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication | Q90854406 | ||
Vasoactive Intestinal Peptide Promotes Corneal Allograft Survival | Q90877081 | ||
Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1 | Q91111156 | ||
Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer | Q91417246 | ||
Exosomes derived from mesenchymal stem cells attenuate the progression of atherosclerosis in ApoE-/- mice via miR-let7 mediated infiltration and polarization of M2 macrophage | Q91440636 | ||
Adaptive immune stimuli altered the cargo proteins of exosomes released by supraneural myeloid body cells in Lampetra japonica | Q91512662 | ||
Exosomes in Inflammation and Inflammatory Disease | Q91537712 | ||
Loss-of-Function Mutations in the CFH Gene Affecting Alternatively Encoded Factor H-like 1 Protein Cause Dominant Early-Onset Macular Drusen | Q92579873 | ||
Low-cost thermophoretic profiling of extracellular-vesicle surface proteins for the early detection and classification of cancers | Q92861259 | ||
Exosomes | Q92910166 | ||
Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis | Q93246335 | ||
Inflammatory Response in Dry Eye | Q93343289 | ||
A look at autoimmunity and inflammation in the eye | Q24623065 | ||
B lymphocytes secrete antigen-presenting vesicles | Q24678522 | ||
Regulation of immune responses by extracellular vesicles | Q27006748 | ||
Routes and mechanisms of extracellular vesicle uptake | Q27023027 | ||
NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis | Q27308853 | ||
Modulation of Immune Responses by Exosomes Derived from Antigen-Presenting Cells | Q28066545 | ||
Allorecognition by T Lymphocytes and Allograft Rejection | Q28067365 | ||
Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
Using exosomes, naturally-equipped nanocarriers, for drug delivery | Q28265872 | ||
Exosomes for repair, regeneration and rejuvenation | Q28272609 | ||
Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles | Q29620600 | ||
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors | Q30239897 | ||
Bovine milk-derived exosomes for drug delivery | Q30696706 | ||
Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration | Q30856906 | ||
MSC-derived Extracellular Vesicles Attenuate Immune Responses in Two Autoimmune Murine Models: Type 1 Diabetes and Uveoretinitis | Q33659353 | ||
Effects of Mesenchymal Stem Cell-Derived Exosomes on Experimental Autoimmune Uveitis | Q33849167 | ||
MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells | Q33922230 | ||
American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort | Q34260251 | ||
Immunotherapeutic strategies in autoimmune uveitis | Q34274950 | ||
Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization | Q34909956 | ||
Human aqueous humor exosomes | Q35155865 | ||
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain | Q35285811 | ||
Characteristics of exosomes andmicroparticles discovered in human tears | Q35955629 | ||
Immune mechanisms in inflammatory and degenerative eye disease | Q36040908 | ||
Macrophage polarization in experimental and clinical choroidal neovascularization | Q36094500 | ||
miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications | Q36213467 | ||
Complement Dysregulation and Disease: Insights from Contemporary Genetics | Q36221928 | ||
T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes | Q36439289 | ||
Exosomes and tumor-mediated immune suppression | Q36737920 | ||
Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium | Q37189227 | ||
Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome | Q37221504 | ||
Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration | Q37331431 | ||
Potential role of corneal epithelial cell-derived exosomes in corneal wound healing and neovascularization | Q37625663 | ||
Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection | Q37731427 | ||
The role of intrinsic epithelial activation in the pathogenesis of Sjögren’s syndrome | Q37777764 | ||
The immunological basis of degenerative diseases of the eye. | Q38077553 | ||
Relationship between the complement system, risk factors and prediction models in age-related macular degeneration | Q38235182 | ||
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. | Q38238059 | ||
Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. | Q38279950 | ||
Exosomes and their roles in immune regulation and cancer | Q38365943 | ||
Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers | Q38463053 | ||
Update on Pathogenesis of Sjögren's syndrome | Q38559605 | ||
Global Survey of Corneal Transplantation and Eye Banking | Q38657885 | ||
The autoimmune diseases of the eyes | Q38665862 | ||
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions | Q38673368 | ||
Roles of exosomes in the normal and diseased eye. | Q38688358 | ||
Directional Exosome Proteomes Reflect Polarity-Specific Functions in Retinal Pigmented Epithelium Monolayers | Q38688817 | ||
Lipids in exosomes: Current knowledge and the way forward | Q38739765 | ||
Management of High-risk Corneal Transplantation | Q38778422 | ||
Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges | Q38795185 | ||
Dry eye disease and uveitis: A closer look at immune mechanisms in animal models of two ocular autoimmune diseases | Q38957664 | ||
Mechanisms and New Strategies for Primary Sjögren's Syndrome | Q39014920 | ||
Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration. | Q39036494 | ||
Drug delivery to the eye: what benefits do nanocarriers offer? | Q39130097 | ||
Exosomes: Therapy delivery tools and biomarkers of diseases | Q39137208 | ||
The emerging roles of tumor-derived exosomes in hematological malignancies | Q39188856 | ||
Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. | Q39269502 | ||
Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa. | Q39317332 | ||
Cutaneous and Mucosal Manifestations of Sjögren's Syndrome | Q40067064 | ||
A2E Suppresses Regulatory Function of RPE Cells in Th1 Cell Differentiation Via Production of IL-1β and Inhibition of PGE2. | Q40238179 | ||
Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells | Q40721019 | ||
Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival. | Q41049928 | ||
Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes | Q41479630 | ||
Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. | Q41542110 | ||
MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. | Q43645305 | ||
Complement factor H in AMD: Bridging genetic associations and pathobiology. | Q46022690 | ||
Adipose-Derived Mesenchymal Stem Cells Reduce Lymphocytic Infiltration in a Rabbit Model of Induced Autoimmune Dacryoadenitis | Q46208181 | ||
Molecular and immunological toxic effects of nanoparticles. | Q46289479 | ||
Clinical and Molecular Inflammatory Response in Sjögren Syndrome-Associated Dry Eye Patients Under Desiccating Stress | Q46656357 | ||
exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. | Q47136994 | ||
Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles | Q47250358 | ||
Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation. | Q47442388 | ||
Inflammation-Stimulated Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Inflammation | Q47596235 | ||
Short peptide analogs as alternatives to collagen in pro-regenerative corneal implants. | Q47720403 | ||
Biomaterials for Regenerative Medicine Approaches for the Anterior Segment of the Eye. | Q48126464 | ||
Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation. | Q48536603 | ||
Emerging role of exosomes in allorecognition and allograft rejection. | Q49494267 | ||
Uveitis: a sight-threatening disease which can impact all systems. | Q49887820 | ||
Shedding light on the cell biology of extracellular vesicles. | Q50018560 | ||
Exosomes Mediate Mobilization of Autocrine Wnt10b to Promote Axonal Regeneration in the Injured CNS. | Q50904756 | ||
Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation. | Q51604864 | ||
Exosomes and Immune Response in Cancer: Friends or Foes? | Q52562641 | ||
Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells. | Q52780389 | ||
Exosomes: Mechanisms of Uptake. | Q54154564 | ||
Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor | Q55062483 | ||
Immune Privilege and Eye-Derived T-Regulatory Cells. | Q55257332 | ||
Exosomes in perspective: a potential surrogate for stem cell therapy | Q57464992 | ||
Exosomes from normal and diabetic human corneolimbal keratocytes differentially regulate migration, proliferation and marker expression of limbal epithelial cells | Q57477054 | ||
Effect of Human Corneal Mesenchymal Stromal Cell-derived Exosomes on Corneal Epithelial Wound Healing | Q58125177 | ||
Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes | Q58762012 | ||
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory | Q64075625 | ||
Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking | Q64086552 | ||
Extracellular vesicles in the tumor microenvironment: old stories, but new tales | Q64100278 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P433 | issue | 1 | |
P921 | main subject | immunity | Q182581 |
eye disease | Q3041498 | ||
P304 | page(s) | 278 | |
P577 | publication date | 2019-08-30 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | Recent advances of exosomes in immune-mediated eye diseases | |
P478 | volume | 10 |
Search more.